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Background: The objective of the study was to determine the relationship between common carotid artery
intima-media thickness (CCA-IMT) and histologically assessed calcification of radial artery in relation to clinical
features and laboratory markers of bone and mineral metabolism, inflammation, and oxidative stress in patients with
stage 5 chronic kidney disease (CKD).
Methods: The study comprised 59 patients (36 hemodialyzed, 23 predialysis). CCA-IMT was measured by
ultrasonography; the biochemical parameters examined were assessed using routine laboratory methods, ELISA
micro-plate immunoassays and spectrophotometry. Fragments of radial artery obtained during creation of
hemodialysis access were cryosectioned and stained for calcifications using von Kossa method and alizarin red.
Results: Glucose, osteoprotegerin, pentraxin 3 and Framingham risk score significantly correlated with CCA-IMT. In
multiple regression analysis, OPG positively predicted CCA-IMT. Radial artery calcifications were found in 34 patients
who showed higher CCA-IMT (0.98 ± 0.13 vs 0.86 ± 0.14 mm; P = 0.006). Higher CCA-IMT values were also associated
with more advanced calcifications. CCA-IMT and the presence of plaques in common carotid artery were positive
predictors of radial artery calcifications, independent of dialysis status, Framingham risk score, CRP and Ca x Pi [OR
for calcifications 2.19 (1.08-4.45) per 0.1 mm increase in CCA-IMT]. The presence of radial artery calcifications was a
significant predictor of mortality, independent of dialysis status and Framingham risk score [HR 3.16 (1.03-9.64)].
Conclusions: In CKD patients, CCA-IMT examination can be used as a surrogate measure to assess the incidence
and severity of arterial medial calcification which is associated with poor clinical outcome in these patients.
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Radial arteryBackground
Vascular calcification, common carotid intima media
thickness (CCA-IMT) and the presence of carotid pla-
ques are strongly associated with cardiovascular disease
in chronic kidney disease (CKD) patients [1, 2]. Arterial
thickening contributes to elevated risk of cardiovascular
episodes in patients on maintenance renal replacement* Correspondence: kasiajanda@op.pl
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unless otherwise stated.therapy. The CCA-IMT, an early marker of vascular
pathology, is commonly used to assess the advancement
of atherosclerosis [3, 4]. In CKD patients, arterial calcifi-
cations occur in two distinct locations: in the tunica in-
tima and in the tunica media [5–7]. Intimal calcification is
observed in atherosclerosis and is associated with inflam-
matory infiltration and stenotic arterial lesions. Whereas
atherosclerosis underlies ischemic heart disease and
stroke, medial arterial calcification (MAC) decreases
arterial compliance and increases arterial stiffening poten-
tially leading to hypertension, left ventricular hypertrophyThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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MAC also occurs in patients with advanced age and
diabetes [5]. Coronary artery calcifications occur in
about 50 % of CKD patients not yet on dialysis [9] and
in 70–90 % of prevalent dialysis patients [10, 11].
The diagnostic procedures aimed at detection of medial
calcification in patients are limited because non-invasive
imaging techniques cannot reliably distinguish it from
intimal calcification associated with atherosclerosis.
Generally, arterial calcification can be detected by plain
radiographs, computed tomography methods including
electron-beam computed tomography (EBCT) and multi-
slice (spiral) computed tomography (MSCT), as well as by
ultrasonography [12, 13].
However, only histological assessment of the vessel
differentiates changes located in the intima and in the
media. The aim of the present study was to determine
whether histologically assessed medial arterial calcifica-
tion is significantly associated with higher CCA-IMT
values and more prevalent cardiovascular events in pa-
tients with stage 5 chronic kidney disease. Moreover, we
examined association between CCA-IMT and vascular
calcification in relation to laboratory markers of bone
and mineral metabolism, inflammation, and oxidative
stress. We used small samples of radial artery wall ob-
tained intravitally during creation of the arteriovenous
fistula for hemodialysis access.
Methods
Study design
The study included patients with stage 5 CKD in whom
arteriovenous fistula was created for the first time for
hemodialysis access, allowing collection of radial artery
samples for histological examination. Cross-sectional
data were obtained immediately before that procedure,
and included clinical assessment of patients, CCA-IMT
measurements and assessment of laboratory parameters
(markers of inflammation, calcification and oxidative
stress). Longitudinal data were collected over a period of
3 following years and included the dates of renal trans-
plantation and the dates and causes of death.
Patients
The study population consisted of 59 consecutive pa-
tients (stage 5 of CKD), including 36 on maintenance
hemodialysis (HD) and 23 predialysis. The majority of
the subjects were men (38, i.e. 64 %). The mean age at
the beginning of the study was 61 ± 16 years. Ten-year
risk of coronary artery disease (CAD) was calculated by
the Framingham Risk Score (FRS) in accordance with
the published guidelines [14].
The intima-media thickness of the common carotid
artery trunk (CCA-IMT) was assessed by ultrasonography
(B presentation, Acuson 128 XP/10 apparatus equippedwith linear head at 5/7 MHz) at the beginning of the
study. The measurements were performed bilaterally at
0.5 cm and 2 cm below the division of the common
carotid artery during diastolic phase of the heart cycle.
The results were expressed as the arithmetic means of the
values obtained for the left and right arteries.
The data on mortality was collected over a period of
three years following creation of arteriovenous fistula for
hemodialysis access. All deaths occurred in the hospital,
therefore the dates and causes of death were determined
on the basis of medical history documentation. The per-
son who collected follow-up data was blind to the results
of cross-sectional part of the study.
The study was approved by the Bioethics Committee
of the Jagiellonian University and all patients signed an
informed consent for their participation.
Laboratory tests
In all patients, selected biochemical parameters were mea-
sured, including serum concentrations of creatinine, glu-
cose, parathyroid hormone (iPTH), total calcium (Ca) and
phosphate (Pi), inflammatory markers: high-sensitivity C-
reactive protein (hsCRP), interleukin-6 (IL-6), pentraxin 3
(PTX3), and circulating calcification markers: osteopontin
(OPN), osteoprotegerin (OPG), osteocalcin (OC), fibro-
blast growth factor 23 (FGF-23) and fetuin A. Oxidative
stress was assessed by measuring ferric reducing ability
of plasma (FRAP), 2,2-diphenyl-1-picrylhydrazyl (DPPH)
scavenging and ferric reducing ability of ascorbate in
plasma (FRASC). Homeostasis Model of Assessment - Insu-
lin Resistance (HOMA-IR) was calculated by application
of the international formula: fasting insulin (μIU/ml) ×
fasting glucose (mmol/l)/22.5. The estimated glomerular
filtration rate (eGFR) was calculated by Modification of
Diet in Renal Disease (MDRD) formula: eGFR = [186 ×
serum creatinine (umol/l) × 0.0113]-1.154 × age-0.203 ×
114 × (0.742 for women) [15].
Blood samples of the patients were obtained at the be-
ginning of the study, on the morning before creation of
arteriovenous fistula for hemodialysis access. Serum sam-
ples for ELISA tests were aliquoted and stored at −70 °C
until assayed (no longer than 3 months). Plasma samples
used to assess oxidative stress parameters were protected
from light, placed on ice and centrifuged within 2 h after
collection, then aliquoted and stored at −30 °C until ana-
lysis (no longer than one month).
Routine biochemical tests were carried out using auto-
matic biochemical analyzers: Hitachi 917 (Hitachi, Japan)
and Modular P (Roche Diagnostics, Mannheim, Germany).
Concentrations of CRP were measured using immuno-
nephelometric method (Nephelometer BN II, Siemens
Healthcare Diagnostics, Germany).
Inflammatory and calcification markers were assessed
using ELISA micro-plate immunoassays and ELX808
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VT, USA). The following kits were applied: IL-6 (R&D
Systems, Minneapolis, MN, USA), PTX3 (R&D Systems),
OPN (R&D Systems), OC (Metra/Quidel, CA, USA), OPG
(BioVendor, Brno, Czech Republic), FGF-23 (Immunoto-
pics Int., San Clemente, CA, USA), fetuin A (BioVendor).
Total antioxidant capacity of plasma was measured as the
ability of plasma to reduce Fe3+ to Fe2+ (ferric reducing
ability of plasma – FRAP), according to Benzie’s method
[16]. Radical scavenging capacity of plasma was estimated
by DPPH radical scavenging assay as described elsewhere
[17]. Ferric reducing ability of ascorbate in plasma
(FRASC) was measured spectrophotometrically.
Histology
Small fragments of radial artery wall, approx. 5 × 2 mm
in size, were collected during the first creation of
arteriovenous fistula for hemodialysis access. The sam-
ples were fixed overnight in 10 % phosphate-buffered
formalin, then rinsed in PBS and soaked in 30 % sucrose.
The material was snap-frozen and tissue blocks were
positioned in a cryostat to allow cutting sections in a
longitudinal plane of the vessel encompassing the entire
thickness of the vascular wall. Serial 10 μm-thick cryo-
sections were cut and thaw-mounted on poly-L-lysine
coated slides. Sections were stained routinely with Mayer’s
haematoxylin and eosin (HE) for general morphology as
well as with von Kossa method and alizarin red for
calcifications. The stained sections were examined under
Olympus BX-50 microscope (Olympus, Tokyo, Japan) in
brightfield mode and the images were acquired using
Olympus DP-71 digital CCD camera controlled by Olym-
pus AnalySIS FIVE software. The advancement of vascular
calcification was semiquantitatively evaluated in von Kossa
and alizarin red-stained sections by two independent
observers. The degree of mineralization was classified
according to the following scale: 0 - no mineral content,
1 - a few small dispersed concretions, 2 - numerous small
dispersed concretions, 3 - larger granular concretions,
4 - large areas occupied by fused mineral deposits.
Since intimal thickening was postulated to be a marker
of vascular pathology, the thicknesses of intima and media
were measured in two distinct locations in sections stained
with HE and mean intima to media (I/M) ratio was
calculated (Fig. 1a).
The reproducibility of the morphological analysis was
confirmed by Bland-Altman method and by calculating
intraclass correlation coefficient (ICC) which was 0.88.
Statistical methods
The data are expressed as the number of patients (per-
centage of the group) for categories and as mean ± SD
or median (lower-upper quartile) for continuous vari-
ables, depending on the distribution, as assessed by theShapiro-Wilk test. Chi-squared test was used to analyze
contingency tables. Student t-test or Mann–Whitney
test were used for simple comparisons between the
groups. For logistic regression models, odds ratios (OR)
were reported with 95 % confidence intervals (95 % CI).
In order to assess the relationship between CCA-IMT and
the degree of vascular calcification, one-way ANOVA with
trend analysis was used. Simple correlations were analyzed
with Spearman rank correlation coefficient. To calculate
the multiple linear regression models, right-skewed vari-
ables were log-transformed; beta +/− standard error (SE)
are reported. Survival times were calculated from the
creation of arteriovenous fistula to death, or censored at
the end of the follow-up, or renal transplantation. They
were analysed using Kaplan-Meier method and compared
with log-rank test. Also, simple and multiple Cox regres-
sion was calculated and hazard ratios (HR) were reported
with 95%CI. All multiple regression models were adjusted
for Framingham risk score and dialysis status at the time
of surgery. The tests were two-tailed and the results were
considered significant at P ≤ 0.05. Statistica 10 software
(StatSoft, Tulsa, OK, USA) was used for the computations.
Results
Characteristics of the study group
Clinical characteristics of the patients and the results of
laboratory tests are presented in Table 1. We also com-
pared these parameters in patients with CCA-IMT above
and below the median value.
Patients with CCA-IMT above the median value were
older, they had higher prevalence of diabetes and heart
failure and higher fasting blood glucose and osteoproteg-
erin. Consequently, the Framingham risk score was also
higher in these patients.
Histological findings
Routine histology (HE staining) revealed the structure of
radial artery with characteristic intimal thickening in the
vast majority of the examined samples (Fig. 1a). The
relative thicknesses of the intima (I/M ratios) varied
between the samples (Table 2). The intimal thickening
was mostly due to the presence of smooth muscle cells.
Atheromatous lesions were not observed. Basophilic
deposits were visible in routinely stained sections of
highly calcified vessels (Fig. 1b). Mineralization of the
arterial wall was visualized by both von Kossa method
and alizarin red staining (Fig. 1 b-f ). However, von Kossa
staining detected calcifications in 17 (29 %) specimens,
while alizarin red demonstrated minerals in 34 samples
(58 %, Table 2). Large and medium-sized mineral de-
posits were successfully visualized by both methods, but
von Kossa staining failed to demonstrate some finest
deposits (grade 1 and 2). Moreover, scores calculated on
the basis of von Kossa method were in most cases lower
Fig. 1 Histology of the radial artery samples. a. Morphology of the routinely (HE) stained vessel showing intimal thickening (I) and no detectable
mineral content. I, intima; M, media; A, adventitia; for I/M ratio calculations thicknesses of intima and media were measured in two locations. b.
Advanced calcification in artery stained with von Kossa method. c-f. Radial artery calcifications of various grades in samples stained with alizarin red
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alizarin red showed higher sensitivity, we adopted this
method for further analysis and for comparison with the
clinical and biochemical data [7].
The mineral deposits were found most frequently in
the vascular media. They presented different degrees
of advancement (Fig. 1c-f ). Smaller minerals were
preferentially seen close to the inner and outer elastic
laminae (Fig. 1d,e).
Correlates of CCA-IMT
Among the studied parameters, fasting blood glucose
(r = 0.37; P = 0.014), osteoprotegerin (r = 0.49; P = 0.002),
pentraxin 3 (r = 0.36; P = 0.027) and FRS (r = 0.47; P =
0.001) were significantly correlated with CCA-IMT in
simple analysis. We noted no significant correlations of
CCA-IMT with other bone markers studied (osteopontin,
osteocalcin, FGF 23, fetuin A), or with other inflammatory
markers (CRP, IL-6) and with indicators of oxidative stress
(FRAP, FRASC, DPPH scavenging). In multiple regression
analysis, only log(OPG) significantly predicted CCA-IMT(beta = 0.41 ± 0.16, P = 0.017), independently of fasting
blood glucose, PTX3, FRS and dialysis status.
Patients with atherosclerotic plaques detected by ultra-
sonography of common carotid artery had higher OPG
[10.40 (7.70-14.15) vs 5.93 (3.56-8.58) pmol/l; P = 0.008].
As expected, the presence of plaques was associated with
significantly higher CCA-IMT (1.04 ± 0.11 vs 0.86 ±
0.13 mm; P < 0.001).
The intima/media ratio measured histologically in
radial artery samples positively correlated with CCA-
IMT (r = 0.35; P = 0.032) (Fig. 2) and FRASC (r = 0.40;
P = 0.008).
Association of CCA-IMT with vascular calcifications
Patients with radial artery calcifications detected by
histology had higher CCA-IMT (0.98 ± 0.13 vs 0.86 ±
0.14 mm; P = 0.006). In patients with CCA-IMT above
the median value (0.925 mm), the incidence of vascular
calcifications was twice as high as in patients with lower
CCA-IMT (79 % vs 37 % of patients; P = 0.033). Also,
higher CCA-IMT values were associated with more severe
Table 1 Clinical and laboratory characteristics of the studied group at the beginning of the study and its comparison in groups with
low CCA-IMT (below median) and high CCA-IMT (above median)
Total cohort (N = 59) CCA-IMT≤median (N = 30) CCA-IMT >median (N = 29) P
Age, years 61+/−16 50+/−16 70+/−11 <0.001
Men, N (%) 38 (64) 18 (60) 20 (69) 0.5
Hemodialysed patients, N (%) 36 (61) 17 (57) 19 (66) 0.5
Dialysis therapy duration, monthsa 7 (2–37) 7 (1–37) 6 (1–32) 0.7
BMI, kg/m2 26.2+/−5.7 25.5+/−3.6 27.3+/−7.8 0.9
Diabetes, N (%) 19 (32) 5 (17) 12 (41) 0.036
Ischemic heart disease, N (%) 29 (49) 11 (37) 18 (62) 0.051
Heart failure, N (%) 13 (22) 3 (10) 10 (34) 0.023
Active smoking, N (%) 17 (29) 6 (20) 11 (38) 0.1
Hypertension, N (%) 26 (44) 15 (50) 11 (38) 0.4
Framingham risk score, points 8 (5–9) 5 (2–8) 9 (6–12) <0.001
Serum creatinine, μmol/l 452 (326–527) 462 (408–527) 410 (32–512) 0.2
eGFR (MDRD), ml/min/1.73 m2b 14 (10–15) 10 (6–11) 10 (9–13) 0.6
Fasting glucose, mmol/l 5.0 (4.6-6.1) 4.8 (4.4-5.1) 5.5 (4.8-8.4) 0.022
Ca x Pi, mmol2/l2 3.05 (2.87-3.86) 3.57 (2.86-4.16) 2.98 (2.88-3.60) 0.2
iPTH, pg/ml 260 (180–453) 266 (204–414) 211 (102–403) 0.5
IL-6, pg/ml 4.20 (2.16-7.52) 2.63 (1.96-6.05) 5.17 (2.94-7.52) 0.3
CRP, mg/l 6.91 (2.97-19.00) 5.15 (2.14-9.73) 8.80 (2.11-22.4) 0.7
PTX 3, ng/ml 1.24 (0.70-2.51) 1.00 (0.68-1.71) 1.55 (0.74-2.26) 0.3
OPN, ng/ml 307 (212–513) 320 (207–588) 281 (217–352) 0.4
OPG, pmol/l 7.55 (4.36-12.00) 5.03 (2.62-9.36) 9.39 (6.76-12.38) 0.031
OC, ng/ml 41.8 (29.0-67.6) 48.7 (35.1-72.7) 33.6 (27.1-42.8) 0.053
Fetuin A 0.245+/−0.052 0.244+/−0.047 0.246+/−0.058 0.6
FGF 23 1013 (416–2529) 1006 (446–1220) 1082 (465–2618) 0.5
FRAP, mM/l 0.77 (0.55-1.14) 0.87 (0.52-1.06) 0.74 (0.57-0.91) 0.9
FRASC, μM/l 50.4+/−13.2 51.2+/−11.7 47.3+/−10.6 0.4
DPPH, % 39.9 (34.4-49.4) 40.5 (37.5-48.1) 36.4 (31.9-44.1) 0.07
CCA-IMT, mm 0.93+/−0.15 0.80+/−0.09 1.05+/−0.08 -
Atherosclerotic plaques in common carotid artery, N (%) 15 (25) 3 (10) 12 (41) 0.006
The median value of CCA-IMT equal to 0.925 mm
adata for hemodialysed patients
bdata for predialysis patients
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P for trend =0.007; Fig. 3). In logistic regression analysis,
CCA-IMT value significantly predicted vascular calcifica-
tions, independently of dialysis status, Framingham risk
score, CRP and Ca x Pi (P = 0.024; Table 3). Similarly, the
presence of atherosclerotic plaques in common carotid ar-
tery detected ultrasonographically was an independent
positive predictor of radial artery calcifications (OR 7.39;
95 % CI 1.03-52.9; P = 0.037).
Association of radial artery calcification and CCA-IMT with
mortality
During 3-year follow-up period, 20 (34 %) patients died,
mostly (18 patients, 90 %) due to cardiovascular causes,including 7 deaths due to myocardial infarction, 3 deaths
due to cerebral stroke and 8 due to heart failure. Two
deaths were due to neoplasms. Seven patients underwent
renal transplantation. The median observation period was
36 (22–36) months; overall, we assessed 140 patient-years.
Lower quartile of survival was 24 months, median survival
was not reached.
Among 34 patients with radial artery calcifications, 16
(47 %) died, including 15 due to cardiovascular causes.
In contrast, there were only 4 deaths (16 %, including 3
cardiovascular) among 25 patients without calcifications
(P = 0.017; Fig. 4). In multiple Cox regression, the presence
of radial artery calcifications was a significant predictor
of all-cause and cardiovascular mortality, independent
Fig. 3 Common carotid artery intima-media thickness (CCA-IMT)
values in patients without radial artery calcifications (alizarin red
staining grade 0), with mild calcifications (grade 1–2) and with
severe calcifications (grade 3–4). Data are shown as median,
interquartile range (box) and range (whiskers); p-value for trend is
shown in the graph
Table 2 Histological parameters of radial arteries in the studied
patients
Radial artery calcification CKD stage 5 patients (N = 59)
Von Kossa staining:
Grade 0 42 (71 %)
Grade 1 2 (3 %)
Grade 2 4 (7 %)
Grade 3 4 (7 %)
Grade 4 7 (12 %)
Alizarin red staining:
Grade 0 25 (42 %)
Grade 1 12 (20 %)
Grade 2 5 (9 %)
Grade 3 9 (15 %)
Grade 4 8 (14 %)
Intima thickness, μm 60.7 (41.4-79.1)
Media thickness, μm 392 (332–461)
Intima/media ratio 0.15 (0.12-0.23)
Number of patients (%) or mean (range)
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95% CI 1.03-9.64; P = 0.043 and HR 3.97; 95% CI 1.13-
14.00; P = 0.032, respectively).
CCA-IMT above the median value was also associated
with more frequent cardiovascular deaths [13 (45 %) vs
5 (17 %) patients, P = 0.020], however, multiple Cox
regression analysis did not confirm this result.
Discussion
This is the first study of vascular calcification aimed at
assessing the correlation between the results of a non-
invasive imaging technique (ultrasound) and histological
findings in the living patients, since the microscopicFig. 2 The correlation between common carotid artery intima-media
thickness (CCA-IMT) and radial artery intima/media ratio. Pearson
correlation coefficient with p-value is shown in the graphstudies of calcified vessels have been mostly performed
on autopsy specimens [18, 19]. The histological examin-
ation of the vessels collected on the occasion of a rou-
tine medical procedure (creation of arteriovenous fistula
for hemodialysis access) enables to assess not only the
severity of calcifications, but also their intimal or medial
location. These locations represent two distinct pro-
cesses of vascular calcification: the intimal calcification
is mostly associated with advancement of atherosclerosis
and has inflammatory background, whereas medial ar-
terial calcification (MAC) develops independently of ath-
erosclerosis and resembles physiological mineralization,
e.g. that of bone tissue [5, 6, 11, 19, 20]. Such calcifica-
tion is commonly observed in diabetes and end stage
renal disease [7, 13, 21–23]. MAC lesions are character-
ized by calcific deposits between smooth muscle cells
and elastic lamine within the media of medium-sized and
small muscular arteries and they do not cause luminal nar-
rowing. Atherosclerosis is characterized by atheromatous
plaques containing lipids, inflammatory cells and matrix
components in the intima of large and medium-sized
arteries [5, 11]. In the present study, mineral deposits
were found almost entirely in the vascular media of
radial arteries. Only very scanty mineral deposits were oc-
casionally seen in the vascular intima and no atheromas
Table 3 Logistic regression models to study the association between CCA-IMT and radial artery calcifications
Predictor variable OR for radial artery calcifications (95 % CI)
Simple model Multiple model 1 Multiple model 2
CCA-IMT, 0.1 mm 1.90 (1.13-3.19) 1.83 (1.02-3.30) 2.19 (1.08-4.45)
Framingham risk score, points - 1.03 (0.87-1.22) 1.06 (0.86-1.29)
CRP, mg/l - - 1.03 (0.97-1.09)
Ca x Pi, mmol2/l2 - - 1.71 (0.54-5.41)
Multiple models 1 and 2 were additionally adjusted for dialysis status
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MAC type calcification in radial arteries of CKD patients
and confirm results of others [19, 24].
Histological studies of vascular calcification usually
employ von Kossa method or alizarin red staining to
demonstrate mineral deposits. We compared both pro-
cedures. In our study, alizarin red staining showed con-
siderably higher sensitivity. Hence, we strongly suggest
the use of alizarin red instead of von Kossa staining for
histological detection of vascular calcification in sam-
ples of human arteries.
Currently, vascular calcification can be clinically assessed
by multislice spiral CT (MSCT) and electron beam CT
(EBCT). These methods are associated with high exposure
to X-ray radiation and they are of high cost. Moreover,
they are not widely available and can be performed only
in specialized diagnostic centers. X-ray imaging allows
to identify extensively calcified lesions and does not dis-
tinguish between the intimal and medial calcifications.
As recently demonstrated, ultrasonography [21, 24] can
be used to detect both types of calcifications, since it
allows to distinguish different layers of the arterial wall.
It also shows higher sensitivity, detecting vascular calci-
fications in higher proportion of cases as compared with
standard X-ray imaging (46 % vs. 21 %). The authors
postulate that ultrasonography could potentially provideFig. 4 Overall survival in patients with (dashed line) and without
(solid line) radial artery calcifications. Numbers at risk at the beginning
and at the end of 1st, 2nd and 3rd year of observation are shown at the
bottom of the graphan alternative method for the diagnosis of MAC but prob-
ably only in large vessels, such as femoral arteries [21].
The predominant type of arterial calcification in CKD
patients still seems to be a matter of controversy. A
study by Coll’s group [24] using ultrasound to determine
the location of mineral lesions in the arteries of dialysed
renal patients demonstrated that vascular calcification of
capacitance arteries was associated with the presence of
atherosclerosis. They studied the presence of vascular
calcifications and atheromatous plaques in carotid, fem-
oral and brachial arteries and found that the most com-
mon type of vascular calcification was linear calcification
of the intima associated with the presence of plaques.
Linear intimal calcification probably corresponds to the
calcification of internal elastic lamina, demonstrated his-
tologically in coronary arteries [25].
Coll and coworkers [24] also concluded that the
absence of carotid plaque was a protective factor for
development of linear calcification. In arteries with a low
prevalence of plaques linear calcification was rarely
observed (7.5 % of patients on dialysis). These results
seem to indicate that the predominant type of vascular
calcification of large arteries in patients on dialysis is
associated with the presence of atherosclerosis.
CCA-IMT was shown to be associated with cardio-
vascular risk factors, prevalent cardiovascular disease,
atherosclerosis and vascular calcification in peripheral
arteries [26]. Earlier reports confirmed the association
of CCA-IMT with coronary artery calcium score (CACS)
and cardiovascular disease not only in patients with
chronic kidney disease [10] but also in patients with dia-
betes type 2 [22] and rheumatoid arthritis [27]. We
demonstrated that the presence of abnormal carotid
IMT (>0.925 mm) led to two times more prevalent
vascular calcification risk. The presence of sonogra-
phically detected atherosclerotic plaques in common ca-
rotid artery was also an independent positive predictor
of radial artery calcifications. As expected, in our study
the presence of plaques was associated with significantly
higher CCA-IMT. Similarly, in a study by Kurnatowska
et al. [10], coronary artery calcification (CAC) occurred
in 70.2 % of dialysis patients and it was significantly
associated with CCA-IMT and with the thickness of
atherosclerotic plaques. Carotid plaque evaluation may
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subgroup of high cardiovascular risk in asymptomatic
diabetic and CKD patients. Thus, measurement of
CCA-IMT might indirectly indicate an increased risk of
MAC and could serve as noninvasive method for asses-
sing overall cardiovascular risk in this population.
Our study confirmed the relationship between CCA-
IMT and cardiovascular risk factors in CKD patients [4, 7,
20, 21, 26, 28]. However, its results show that not only the
classical risk factors can affect the intima-media thickness.
Although patients with CCA-IMT above the median
value were older, had higher prevalence for diabetes,
heart failure and higher concentrations of fasting blood
glucose and osteoprotegerin, in multiple regression ana-
lysis, only log(OPG) was an independent predictor for
IMT. The association of CCA-IMT with OPG level was
also observed by us in CKD patients on peritoneal dialy-
sis [29]. In another study, both increased CACS as well
as CCA-IMT positively correlated with baseline and
follow-up serum OPG. The patients who died had sig-
nificantly higher baseline CACS and serum OPG [10].
Osteoprotegerin (OPG), a member of the tumor necrosis
factor receptor family, has been identified as a regulator of
bone resorption and inhibitor of vascular calcification. In-
creased levels of OPG in CKD patients with vascular calci-
fications can represent a response to mineral disorders
and constitute a compensatory mechanism.
Our study confirmed earlier reports demonstrating high
cardiovascular mortality associated with vascular calcifi-
cation not only in dialyzed patients [20, 30, 31] but also
in CKD patients not yet on dialysis [23]. The presence
of radial artery calcifications was a significant predictor of
mortality, independent of dialysis status and Framingham
risk score.
In summary, our results indicate that both medial ar-
terial calcification and intimal atherosclerotic changes
frequently coexist in CKD patients. Elevated CCA-IMT
is associated with higher incidence and severity of med-
ial arterial calcification which in turn predicts adverse
clinical outcomes and higher mortality in such patients.
Conclusions
In CKD patients, sonographic examination of CCA-IMT
can be used as an early, non-invasive screening method
assessing the risk of arterial medial calcification and
identifying patients at high risk of cardiovascular disease.
That would allow for early prevention and reduction of
mortality in these patients.
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